2016
DOI: 10.1530/endoabs.41.ep1015
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular risk assessment using serum hs-CRP and Framingham risk score in newly diagnosed Graves' disease patients

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles